A rapid monitoring method of paraquat and diquat in serum and urine using ion-pairing bare-silica stationary phase HPLC following a single acidification step of sample pretreatment
A rapid monitoring method of paraquat and diquat in serum and urine using ion-pairing bare-silica stationary phase HPLC following a single acidification step of sample pretreatment
复制标题
DOI:
10.1080/10826079708005835
复制
发表时间:
1997-01-01
影响因子:
1.3
通讯作者:
Binder, SR
中科院分区:
文献类型:
--
作者:
Itagaki, T;Lai, SJ;Binder, SR
Intoxication by paraquat, an agricultral chemical, is frequently reported in Asian and eastern European countries because of its availablity by general population. Because paraquat is not significantly biotransformed in man, it requires an intensive monitoring of paraquat level during both stages of rescue and recuperation. It is critical to design an effective technique to eliminate the paraquat from the patient at the earlier stage of the therapy, and a rapid method is required for monitoring the paraquat concentration. Diquat is a less toxic analog of paraquat, and is often mixed with paraquat for agricultural usage. Recently, a high rate of fatal cases were reported on the mixture of diquat and paraquat among all been developed for monitoring paraquat and diquat in serum and urine samples.The total analysis is less than 6 minutes. It only requires a minimal sample pretreatment, including acidification and centrifugation of sample at 9500 x g for 1 minute. This method utilizes ion-pairing HPLC with bare silica (150 mm X 4.6 mm) as stationary phase. After acidification with 2M phosphoric acid, the supernatant of samples can be injected directly into the HPLC system. The mobile phase was 25/75 acetonitrile/water (VN); containing 10 mM 1- Heptanosulphonic Sodium Salt, 4 mM potassium phosphate, 10 mM potassium chloride, pH 3.0. The analysis was performed at room temperature with a flow rate of 1.0 mL/min. The-optimum UV wavelength for paraquat and diquat were 257 nm and 310 nm, respectively; the corresponding detection limits were measured at 63 ng/mL (1.25 ng on column) for diaquat and 125 ng/mL (2.5 ng on column) for paraquat, respectively. For simultaneous monitoring of both compounds, a common wavelength of 290 mn can be used; with an injection volume of 20 mu L, paraquat could be detected at 500 ng/mL(10 ng on column) and 125 ng/mL (2.5 ng on column) for diquat in both urine and serum. A lower detection limit at 290 nm can be achieved by using a larger injection volume. The CV% of retention data are less than 1.2% for both compounds. Interference studies were also conducted for common drugs and metabolites. Additional tests were conducted on drugs which are strongly retained on cation exchange methods: chloroquine, strychnine and nicotine. All these three compounds did not interfere with the method.